Form 4: AtriCure's Chief Legal Officer Sells Shares Under 10b5-1 Trading Plan

Karl S. Dahlquist, Chief Legal Officer of AtriCure, Inc., sold 1,885 shares of common stock at $32.16 per share on March 18, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On March 18, 2024, Karl S. Dahlquist, the Chief Legal Officer of AtriCure, Inc., sold 1,885 shares of the company's common stock.
• The sale was executed at a price of $32.16 per share.
• This transaction was conducted under a 10b5-1 trading plan that was adopted on February 24, 2023.
• Following the transaction, Dahlquist directly owns 50,954 shares of AtriCure common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment, but rather a routine transaction.

Industry Context

Sales by insiders are a normal part of corporate activity. The use of a 10b5-1 trading plan suggests the insider is selling shares according to a pre-arranged schedule to avoid accusations of trading on inside information. It is common for executives to diversify their holdings or exercise stock options and sell the underlying shares.

Stakeholder Impact

• The sale of shares by an officer could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates